"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration (FDA) has approved lenalidomide (Revlimid) as maintenance therapy for multiple myeloma (MM) patients after autologous hematopietic stem cell transplantation (auto-HSCT). Read full press release.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451